IFNA1 and rheumatoid arthritis: The IFN-signaling pathway contributes to the transition from pre-clinical RA to a clinically persistent disease, mainly through driving an aggressive immune response via lymphocyte proliferation, altered cellular metabolism, and differentiation into effector subsets.